Goldline Pharmaceutical Limited (BOM:544759)
29.60
+0.33 (1.13%)
At close: Nov 16, 2026
| Market Cap | 284.16M |
| Revenue (ttm) | n/a +11.2% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 9.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,000 |
| Open | 29.99 |
| Previous Close | 29.27 |
| Day's Range | 29.60 - 30.00 |
| 52-Week Range | 28.13 - 60.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 14, 2026 |